<DOC>
	<DOC>NCT02606916</DOC>
	<brief_summary>This Prospective, single-arm Phase Ⅱ study is to determine the efficacy and safety of Once-daily Simultaneous Modulated Accelerated Radiotherapy combined with S-1/DDP for geratic esophageal squamous cell carcinoma patients.</brief_summary>
	<brief_title>Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Pathologically or cytologically confirmed esophageal squamous cell carcinoma. Stage IIIVa ESCC confirmed by endoscopic ultrasonography(EUS) and imaging studies. Aging from 70 to 80. Eastern Cooperative Oncology Group (ECOG) performance status 02. Charlson's weighted index of comorbidities (WIC) ≤4； White blood cell count ≥4×109 /L, neutrophile granulocyte count≥1.5×109 /L, platelet count≥100×109 /L, hemoglobin ≥100 g /L, serum creatinine and bilirubin 1.5 times less than the upper limits of normal (ULN),aminotransferase two times less than the ULN. Weight loss ≤15% within the past half year. Forced expiratory volume in 1 s≥ 1 L. Patients and their family signed the informed consents. Previous or recent another malignancy, except for nonmelanoma skin cancer or cervical cancer in situ. Already received antineoplastic therapy,including chemotherapy, radiotherapy or operation. Any contraindication for chemotherapy or radiotherapy(such as a myocardial infarction within 6 months,immunosuppressive therapy,symptomatic heart disease,including unstable angina pectoris, congestive heart failure,and uncontrolled arrhythmia.) Malignant pleural effusion or pericardial effusion. Weight loss &gt;10% within the past 3 months. Recruited in other clinical trials within 30 days Drug addiction, longterm alcohol abuse and AIDS patients. Uncontrollable epileptic attack or psychotic patients without selfcontrol ability. Severe allergy or idiosyncrasy. Not suitable for this study judged by researchers.</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Once-daily Simultaneous Modulated Accelerated Radiotherapy</keyword>
	<keyword>S-1</keyword>
	<keyword>DDP</keyword>
	<keyword>elderly patients</keyword>
</DOC>